XML 40 R30.htm IDEA: XBRL DOCUMENT v3.22.2
REVENUES (Tables)
 6 Months Ended
Jun. 30, 2022
Revenue from Contract with Customer [Abstract]  
Contract with Customer, Contract Asset
The following table summarizes our contract assets:
(in millions)June 30,
2022		December 31,
2021
Contract manufacturing services$62 $50 
Software sales41 45 
Bundled equipment and consumable medical products contracts120 100 
Contract assets$223 $195 
The following table summarizes the classification of contract assets and contract liabilities as reported in the condensed consolidated balance sheets:
(in millions)June 30,
2022		December 31,
2021
Prepaid expenses and other current assets$102 $84 
Other non-current assets121 111 
Contract assets$223 $195 
Accrued expenses and other current liabilities$153 $162 
Other non-current liabilities80 84 
Contract liabilities$233 $246 
The following table summarizes contract liability activity for the six months ended June 30, 2022. The contract liability balance represents the transaction price allocated to the remaining performance obligations.
Six months ended
June 30, 2022
Balance at beginning of period$246 
New revenue deferrals282 
Revenue recognized upon satisfaction of performance obligations(290)
Currency translation(5)
Balance at end of period$233 
Net Sales from Contracts with Customers by Global Business Unit The following tables disaggregate our net sales from contracts with customers by product category between the U.S. and international:
Three Months Ended June 30,
20222021
(in millions)U.S.InternationalTotalU.S.InternationalTotal
Renal Care 1
$225 $706 $931 $217 $747 $964 
Medication Delivery 2
459 251 710 444 253 697 
Pharmaceuticals 3
164 364 528 162 384 546 
Clinical Nutrition 4
90 140 230 84 153 237 
Advanced Surgery 5
151 112 263 144 112 256 
Acute Therapies 6
58 115 173 61 127 188 
BioPharma Solutions 7
75 88 163 65 118 183 
Patient Support Systems 8
284 80 364 — — — 
Front Line Care 9
202 80 282 — — — 
Surgical Solutions 10
36 33 69 — — — 
Other 11
20 13 33 21 6 27 
Total Baxter$1,764 $1,982 $3,746 $1,198 $1,900 $3,098 
Six Months Ended June 30,
20222021
(in millions)U.S.InternationalTotalU.S.InternationalTotal
Renal Care 1
$450 $1,375 $1,825 $433 $1,453 $1,886 
Medication Delivery 2
931 485 1,416 855 494 1,349 
Pharmaceuticals 3
321 728 1,049 362 736 1,098 
Clinical Nutrition 4
174 283 457 167 304 471 
Advanced Surgery 5
287 204 491 270 203 473 
Acute Therapies 6
126 235 361 142 253 395 
BioPharma Solutions 7
127 192 319 109 209 318 
Patient Support Systems 8
579 168 747 — — — 
Front Line Care 9
409 167 576 — — — 
Surgical Solutions 10
73 74 147 — — — 
Other 11
44 21 65 40 14 54 
Total Baxter$3,521 $3,932 $7,453 $2,378 $3,666 $6,044 
1Renal Care includes sales of our peritoneal dialysis (PD), hemodialysis (HD) and additional dialysis therapies and services.
2Medication Delivery includes sales of our intravenous (IV) therapies, infusion pumps, administration sets and drug reconstitution devices.
3Pharmaceuticals includes sales of our premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services.
4Clinical Nutrition includes sales of our parenteral nutrition (PN) therapies and related products.
5Advanced Surgery includes sales of our biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention.
6Acute Therapies includes sales of our continuous renal replacement therapies (CRRT) and other organ support therapies focused in the intensive care unit (ICU).
7BioPharma Solutions includes sales of contracted services we provide to various pharmaceutical and biopharmaceutical companies.
8Patient Support Systems includes sales of our connected care solutions: devices, software, communications and integration technologies.
9Front Line Care includes sales of our integrated patient monitoring and diagnostic technologies to help diagnose, treat and manage a wide variety of illness and diseases, including respiratory therapy, cardiology, vision screening and physical assessment.
10Surgical Solutions includes sales of our surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories.
11Other includes sales of miscellaneous product and service offerings.
Sales-type Lease, Lease Income
The components of lease revenue for the three and six months ended June 30, 2022 and 2021 were:
(in millions)Three months ended June 30, 2022Six months ended June 30, 2022
Sales-type lease revenue$5 $8 
Operating lease revenue113 235 
Variable lease revenue12 32 
Total lease revenue$130 $275 
(in millions)Three months ended June 30, 2021Six months ended June 30, 2021
Sales-type lease revenue$10 $16 
Operating lease revenue35 69 
Variable lease revenue15 32 
Total lease revenue$60 $117 
Operating Lease, Lease Income
The components of lease revenue for the three and six months ended June 30, 2022 and 2021 were:
(in millions)Three months ended June 30, 2022Six months ended June 30, 2022
Sales-type lease revenue$5 $8 
Operating lease revenue113 235 
Variable lease revenue12 32 
Total lease revenue$130 $275 
(in millions)Three months ended June 30, 2021Six months ended June 30, 2021
Sales-type lease revenue$10 $16 
Operating lease revenue35 69 
Variable lease revenue15 32 
Total lease revenue$60 $117